An important scientific benchmark that has lasted for over seven decades has been broken by artificial intelligence (AI). A ...
A blood sample small enough to come from a finger prick, paired with a set of online thinking tests, may offer a new way to sort who faces the greatest risk of dementia. This approach could do so ...
Nearly one million people in the UK are thought to be living with dementia, says the University of Exeter Medical School Scientists say a simple at-home test could spot someone's risk of Alzheimer's ...
A finger prick blood test combined with online brain testing—all done from home—could one day effectively identify people's risk of developing dementia, according to a new study. The research ...
A finger prick blood test combined with online brain testing - all done from home - could one day effectively identify people’s risk of developing dementia, according to a new study. Led by the ...
Farmingdale car crash victim taken off life support at NUMC after tests determined no brain activity
A 23-year-old Farmingdale man, who had remained in a coma since a car crash nearly three weeks ago, was taken off life support Wednesday night at Nassau University Medical Center, a family member said ...
A US company has tested a brain implant in a Chinese patient in Shanghai, a rare sign of cooperation as the two countries compete to develop the most advanced neurotechnology. The Cambridge company, ...
The family of a 23-year-old Farmingdale man, left comatose at Nassau University Medical Center following an April 9 car crash, has until Wednesday evening to arrange transport to another medical ...
Brandon Patterson has been through a lot in the nine years since rolling a Jeep left him paralyzed. Now he's on the leading edge of science. Patterson, 41, had a brain-computer interface implanted in ...
At last year’s AD/PD meeting in Vienna, what is now the Consortium for Biomedical Research and AI in Neurodegeneration was an idea. By this year’s AD/PD in Copenhagen, C-BRAIN had become an operating ...
The Icahn School of Medicine at Mount Sinai today announced the enrollment of its first patient in a U.S. Department of Defense-funded pivotal clinical trial to evaluate whether a fast-acting, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results